DelphX Announces Grant of Stock Options
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), a leader in developing new structured products for the fixed income market, has announced the grant of 1,650,000 stock options to eligible participants under its stock option plan. The Board of Directors approved this grant with the following terms:
- Two-year maturity
- Exercise price of $0.25 per common share
- Options are exercisable for common shares of DelphX
This decision aligns with the company's stock option plan and may be seen as a strategy to incentivize and retain key personnel or partners.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), un leader nello sviluppo di nuovi prodotti strutturati per il mercato dei redditi fissi, ha annunciato l'assegnazione di 1.650.000 opzioni su azioni ai partecipanti idonei nell'ambito del suo piano di opzioni su azioni. Il Consiglio di Amministrazione ha approvato questa assegnazione con i seguenti termini:
- Scadenza di due anni
- Prezzo di esercizio di $0,25 per azione comune
- Le opzioni possono essere esercitate per azioni comuni di DelphX
Questa decisione è in linea con il piano di opzioni su azioni dell'azienda e può essere vista come una strategia per incentivare e trattenere personale chiave o partner.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), un líder en el desarrollo de nuevos productos estructurados para el mercado de renta fija, ha anunciado la concesión de 1.650.000 opciones sobre acciones a participantes elegibles bajo su plan de opciones sobre acciones. La Junta de Directores aprobó esta concesión con los siguientes términos:
- Vigencia de dos años
- Precio de ejercicio de $0.25 por acción común
- Las opciones son ejercitables por acciones comunes de DelphX
Esta decisión se alinea con el plan de opciones sobre acciones de la compañía y puede verse como una estrategia para incentivar y retener a personal clave o socios.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), 고정 수입 시장을 위한 새로운 구조화된 제품 개발의 선두주자, 은 주식 옵션 계획에 따라 1,650,000개의 주식 옵션을 자격이 있는 참가자에게 부여한다고 발표했습니다. 이사회는 다음과 같은 조건으로 이 부여를 승인했습니다:
- 2년 만기
- 주당 $0.25의 행사 가격
- 옵션은 DelphX의 보통주로 행사할 수 있습니다
이 결정은 회사의 주식 옵션 계획과 일치하며, 주요 인력이나 파트너를 유인하고 유지하기 위한 전략으로 볼 수 있습니다.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), un leader dans le développement de nouveaux produits structurés pour le marché des titres à revenu fixe, a annoncé l'octroi de 1 650 000 options d'achat d'actions à des participants éligibles dans le cadre de son plan d'options d'achat d'actions. Le Conseil d'administration a approuvé cet octroi avec les conditions suivantes :
- Durée de deux ans
- Prix d'exercice de 0,25 $ par action ordinaire
- Les options peuvent être exercées pour des actions ordinaires de DelphX
Cette décision est conforme au plan d'options d'achat d'actions de l'entreprise et peut être interprétée comme une stratégie visant à inciter et à retenir des personnes clés ou des partenaires.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), ein Führer in der Entwicklung neuer strukturierter Produkte für den festverzinslichen Markt, hat die Gewährung von 1.650.000 Aktienoptionen an berechtigte Teilnehmer im Rahmen seines Aktienoptionsplans bekannt gegeben. Der Vorstand hat diese Gewährung mit den folgenden Bedingungen genehmigt:
- Zweijährige Laufzeit
- Ausübungspreis von $0,25 pro Stammaktie
- Die Optionen sind für Stammaktien von DelphX ausübbar
Diese Entscheidung steht im Einklang mit dem Aktienoptionsplan des Unternehmens und kann als Strategie verstanden werden, um Schlüsselpersonen oder Partner zu incentivieren und zu binden.
- Grant of 1,650,000 stock options to eligible participants, potentially aligning interests with shareholders
- Two-year maturity on options, encouraging medium-term commitment
- Potential dilution of existing shareholders if options are exercised
Toronto, Ontario--(Newsfile Corp. - September 23, 2024) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products for the fixed income market, announces that its Board of Directors has approved the grant of 1,650,000 stock options (the "Options") to eligible participants under its stock option plan (the "Plan"). The Options have a two-year maturity and are exercisable for common shares of DelphX at an exercise price of
About DelphX Capital Markets Inc.
DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables fixed income dealers to offer new private placement securities that provide mitigation of spread and capital charge losses when downgrades occur, while allowing for attractive returns. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:
- Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds;
- Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade exposure of an underlying security in exchange for attractive returns.
All CPOs and CRNs are fully collateralized and held in custody by BNY Mellon. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.
For more information about DelphX, please visit www.delphx.com.
George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/224213
FAQ
How many stock options did DelphX Capital Markets (DPXCF) grant on September 23, 2024?
What is the exercise price for the stock options granted by DelphX (DPXCF)?
What is the maturity period for the stock options granted by DelphX Capital Markets (DPXCF)?
On which stock exchanges is DelphX Capital Markets traded?
